4 ETFs Yielding Up to 9.25% That Belong in Every Income Portfolio in 2026

Core Insights - The article discusses four ETFs that yield between 7% and 9.25%, highlighting their unique strategies and potential benefits for income-focused investors in 2026 [1][2] Group 1: ETF Summaries - JPMorgan Premium Income (JEPI): This ETF yields 7.56% with $45 billion in assets, utilizing a covered call strategy on a diversified portfolio of large-cap stocks. It aims to provide monthly income while managing volatility, but caps upside potential during strong market rallies [1][2] - FT Vest Aristocrats (KNG): KNG targets companies that have consistently raised dividends for at least 25 years, layering a covered call strategy to enhance yield. It offers stable monthly distributions ranging from $0.344 to $0.363, with a focus on quality holdings like Johnson & Johnson and Coca-Cola [1][2] - VanEck BDC Income (BIZD): This ETF yields 9.25% and focuses on Business Development Companies (BDCs) that lend to middle-market firms at floating rates. It is sensitive to interest rate changes and has seen a 10% decline year-to-date, making it suitable for investors who actively monitor credit quality [1][2] - Global X SuperDividend (SDIV): SDIV yields 7.26% and invests in 100 high-yielding global dividend stocks. It has a diverse portfolio but requires careful monitoring due to a history of distribution cuts, indicating potential financial stress among some holdings [1][2] Group 2: Investment Considerations - JEPI is characterized by its liquidity and low expense ratio of 0.35%, making it appealing for income-seeking investors who prefer reduced volatility [1][2] - KNG's higher expense ratio of 0.74% is justified by its consistent income generation from high-quality dividend-paying companies [1][2] - BIZD's high yield comes with floating-rate credit risk, making it less suitable for passive investors [1][2] - SDIV's global diversification is attractive, but its past distribution cuts highlight the need for ongoing evaluation of the underlying companies' financial health [1][2]